Entero Healthcare Solutions
add_icon

Entero Healthcare Solutions

1,195.80
+10.40
(0.88%)
Market Cap
5,203.04 Cr
PE Ratio
35.44
Volume
2,19,531.00
Day High - Low
1,204.10 - 1,154.00
52W High-Low
1,485.00 - 944.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
5,203.04 Cr
EPS
26.44
PE Ratio
35.44
PB Ratio
3.06
Book Value
388.03
EBITDA
257.77
Dividend Yield
0.00 %
Industry
Retail
Return on Equity
6.07
Debt to Equity
0.22
Analyst Rating and Forecast
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Entero Healthcare Solutions Limited will hold an earnings call for Q4FY26 on May 26, 2026, at 12:00 pm IST. Management will discuss audited financial results for the quarter and year ended March 31, 2026.
neutral
MCA's Southern Region office approved the amalgamation of Chethana Pharma Distributors and CPD Pharma Private Limited with Rada Medisolutions, effective April 15, 2025.
neutral
Entero Healthcare Solutions Limited filed mandatory certificate under SEBI Depositories Regulations for quarter ended March 31, 2026, confirming proper dematerialization processes by registrar MUFG Intime India.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
895.20
#1 10,747.29
48.22
#1 6,892.47
11.44
#1 198
24.76
50.90
1,195.80
#2 5,203.04
#1 35.44
#2 6,591.21
#2 28.35
#2 120
#1 43.63
45.32
99.50
194.31
38.54
117.90
#1 99.16
5
-
60.16
56.00
118.10
-
9.20
-4.17
-2
-166.67
55.82

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
28.35 %
Net Income Growth
11.60 %
Cash Flow Change
-109.97 %
ROE
150.83 %
ROCE
67.13 %
EBITDA Margin (Avg.)
-5.11 %

Quarterly Financial Results

Quarterly Financials
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
832
888
901
998
994
1,043
1,111
1,312
1,367
1,346
1,410
1,576
1,711
1,914
Expenses
810
867
873
968
964
1,005
1,067
1,258
1,309
1,290
1,354
1,509
1,647
1,824
EBITDA
21
21
27
31
30
38
44
54
58
56
56
67
64
90
Operating Profit %
2 %
2 %
3 %
3 %
3 %
3 %
3 %
3 %
4 %
4 %
4 %
4 %
3 %
5 %
Depreciation
5
7
6
6
6
7
7
8
8
9
9
10
10
15
Interest
13
13
14
18
16
17
10
12
10
11
11
12
14
17
Profit Before Tax
3
1
7
7
8
14
27
35
39
37
36
45
40
58
Tax
-1
5
0
2
1
-8
7
9
10
6
6
8
7
13
Net Profit
4
-4
6
5
7
21
21
26
30
31
30
37
34
45
EPS in ₹
8.67
1.49
15.18
3.24
4.21
5.73
4.62
5.43
5.85
5.91
6.39
7.26
6.35
6.44

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
2026
Total Assets
749
836
1,126
1,309
2,345
2,703
3,600
Fixed Assets
186
189
262
268
289
559
211
Current Assets
552
636
851
1,023
2,011
2,076
2,508
Capital Work in Progress
2
2
1
0
0
0
0
Investments
0
0
0
0
0
58
842
Other Assets
561
645
863
1,041
2,056
2,085
0
Total Equity & Liabilities
749
836
1,126
1,309
2,345
2,703
3,600
Current Liabilities
269
291
462
624
602
845
1,588
Non Current Liabilities
56
58
101
87
102
87
260
Total Equity
424
487
563
598
1,641
1,770
1,689
Reserve & Surplus
-16
-32
-62
-73
1,593
1,676
1,645
Share Capital
439
517
4
4
44
44
44

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
-23
-11
14
-21
122
82
Investing Activities
-203
-31
-162
-49
-704
232
Operating Activities
-37
-69
-35
-45
-37
-77
Financing Activities
217
89
211
73
863
-74

Share Holding

% Holding
Sept 2023
Feb 2024
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
78.85 %
52.44 %
52.44 %
52.44 %
52.44 %
52.44 %
52.42 %
52.42 %
52.42 %
52.42 %
52.42 %
FIIs
0.00 %
0.00 %
23.30 %
23.32 %
23.82 %
22.21 %
19.92 %
17.20 %
14.67 %
5.14 %
4.03 %
DIIs
0.00 %
1.36 %
2.28 %
2.06 %
7.73 %
8.77 %
9.64 %
10.18 %
9.65 %
16.42 %
16.62 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
5.72 %
4.95 %
5.00 %
4.06 %
4.36 %
5.41 %
6.99 %
9.36 %
11.56 %
12.25 %
Others
21.15 %
40.48 %
17.03 %
17.18 %
11.95 %
12.23 %
12.61 %
13.20 %
13.90 %
14.46 %
14.68 %
No of Share Holders
51
58
80,864
66,400
36,767
33,172
33,159
33,338
36,334
40,332
39,083

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
19 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Aug 2026 1,354.40 1,195.80
28 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Aug 2024 1,245.00 1,301.20
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 1,387.70 1,477.80
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 1,372.25 1,328.65
27 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2025 1,443.60 1,477.30
08 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Aug 2025 1,265.95 1,257.25
18 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
18 Sept 2025 1,158.70 1,132.30
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 1,111.35 1,089.00
12 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2026 1,131.80 1,148.70
25 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 May 2026 1,192.80 1,354.40

Announcements

Clarification On Investor Queries Relating To Profit Attributable To Owners Of The Company And Minority Interest For The Quarter Ended 31St March 20262 days ago
Compliances-Reg.24(A)-Annual Secretarial Compliance3 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome4 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation5 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS5 days ago
The Board Approved The Re-Appointment Of Internal Auditor M/S. Ernst & Young LLP (EY) For The Next Financial Year 2026-27.5 days ago
The Grant Of Fresh 7300 (Seven Thousand Three Hundred) Employee Stock Options Under The Existing Entero Employee Stock Option Plan 2023.5 days ago
Announcement under Regulation 30 (LODR)-Change in Management5 days ago
Announcement under Regulation 30 (LODR)-Acquisition5 days ago
Announcement under Regulation 30 (LODR)-Allotment5 days ago
Board Meeting Outcome for Outcome Of Board Meeting May 25 20265 days ago
Results - Financial Year 2025-265 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20117 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results/Statements For The Quarter And Year Ended March 31 2026.May 18, 2026
Announcement under Regulation 30 (LODR)-Scheme of ArrangementMay 06, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Closure of Trading WindowMar 23, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 11, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 26, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 20, 2026
Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025 With UDINFeb 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 13, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 12, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 12, 2026
Intimation For Grant Of Fresh 5000 ESOPFeb 12, 2026
Submission Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 12, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On February 12 2026Feb 12, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 09, 2026
Update On AcquisitionFeb 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2026
Board Meeting Intimation for Approval Of The Financial Results For The Quarter Ended December 31 2025Feb 03, 2026
Disclosure Pursuant To Regulation 30 Of SEBI (LODR) Regulations 2015.Jan 27, 2026
Change Of Name Of M/S. M S K A & Associates Chartered Accountants Statutory Auditor Of The Company - Upon Conversion Of Firm Into LLPJan 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Dec 31, 2025
Closure of Trading WindowDec 23, 2025
Intimation For Grant Of 73060Options Pursuant To "Entero Employees Stock Options Plan 2023" To The Eligible Employees Of The CompanyDec 06, 2025
Announcement under Regulation 30 (LODR)-Credit RatingDec 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 27, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 13, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 12, 2025

Technical Indicators

RSI(14)
Neutral
45.32
ATR(14)
Less Volatile
63.25
STOCH(9,6)
Neutral
59.41
STOCH RSI(14)
Neutral
23.00
MACD(12,26)
Bearish
-3.62
ADX(14)
Weak Trend
19.48
UO(9)
Bearish
49.52
ROC(12)
Downtrend And Accelerating
-1.20
WillR(14)
Neutral
-76.94